Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins.

Source:http://linkedlifedata.com/resource/pubmed/id/12719551

Download in:

View as

General Info

PMID
12719551